As the Chief Executive Officer of one of the largest behavioral health organizations in the nation, Wayne Young is passionate about the planning and delivery of large-scale behavioral health and intellectual and developmental disabilities services to a population who rely upon safety net systems of care. Wayne previously served as the chair of the Texas Health and Human Services Commission’s Behavioral Health Advisory Council and currently services on Texas HHSC’s Joint Forensic Committee on Access and Forensic Services. He was recently appointed by the Supreme Court of Texas to the Texas Judicial Commission on Mental Health and also service as a board member of the National Association of Addiction Treatment Providers. Wayne was honored to have received the Charley H. Shannon Advocate for Justice Award from NAMI Texas in 2019 as well as to have been named to Modern Healthcare’s list of Top 25 Innovators in 2019 and again 2021.  In 2023, Wayne was recognized as one of Houston’s Most Admired CEO’s. While honored by individual recognitions, Wayne is most proud to have been a part of The Harris Center as it received the Excellence Award for Innovation from the National Council on Behavioral Health and was named as a Best Place to Work by The Houston Business Journal who also honored them with a Diversity in Business Award in 2023 and 2024. 

The Harris Center for Mental Health and IDD is the state-designated Local Mental Health Authority and Local Intellectual and Developmental Disability Authority for Harris County, Texas.  

Dr. Michael Dennis received his PhD in Psychology from Northwestern University under a NIH fellowship to train more methodologists in how to implement and improve the quality of community-based behavioral health research. His dissertation was on implementing randomized field experiments in criminal and civil justice research to improve their impact on practice. He currently serves as Director of the Lighthouse Institute (LI), a division of Chestnut Health Systems conducting community-based research, program evaluation, and training on evidence-based practices. LI currently has offices in Bloomington-Normal and Chicago, Illinois and Eugene, Oregon; offsite staff in over two dozen states; over 110 LI staff operating four major centers related to training on assessment, evidence-based treatment, family coaching, program evaluation; and a Native-led national Native Center of Excellence. LI works with community-based agencies in all 50 of the United States, four U.S. territories, and over four dozen tribal serving agencies, as well as all Canadian provinces and over a dozen other countries. Part of LI’s community focus includes the use of service cascades, simplified time series, and economic analysis from the agency and funder perspectives to aid in program planning and management. In addition to supporting a diverse workforce that reflects the communities we serve, LI is working to become a home for supporting the career development and work of researchers with personal lived experience in addiction, recovery, and the legal system.  

As a senior research scientist, Dr. Dennis is currently the Principal Investigator (PI) of the Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) experiment (DA011323) and a Multiple PI (with Dr. Christine Grella) of Improving Retention across the OUD Service Cascade upon Reentry from Jail using Recovery Management Checkups (UG1DA050065). The latter is part of NIDA’s HEAL Justice Community Opioid Innovation Network (JCOIN) cooperative. He also serves as the Co-Investigator on Dr. Dennis Watson’s Recovery Management Checkups for Primary Care (RMCPC) experiment (R01AA024440); Dr. Chris Grella’s Recovery Initiation and Management after Overdose (RIMO) Experiment (R33DA045774); and Dr. Kate Elkington’s Original and Scaling up eConnect in Juvenile Probation Settings, a hybrid implementation effectiveness trial of a digital suicide risk/behavior identification and linkage-to-treatment system (MH113599, MH130845).  

In the past, he has been the Coordinating Center PI on the Juvenile Justice Translational Research for Adolescents in the Legal System (JJ-TRIALS; U01DA036221) cooperative agreement and the Cannabis Youth Treatment experiment, as well as Dr. Chris Scott’s Recovery Management Checkups for Woman Offenders Experiment (5R01DA21174). JJ-TRIALS is one of the largest and most recent studies of transitional research with adolescents and included national surveys of juvenile justice community supervision to examine their behavioral health services related to suicide, mental health, substance use, and HIV risk reduction. The study also included a multisite experiment to examine LI’s ability to improve the behavioral health service cascades from the justice system to behavioral health (e.g., screening, identification, need, referral, treatment initiation, engagement, and continuing care). HEAL supplements were also used to conduct surveys of a census of the state prison systems and county jails hardest hit by the opioid epidemic. The Cannabis Youth Treatment (CYT) experiment was one of the first to evaluate five manualized approaches compared on a large sample of youth and families studied (600), with high rates of participation, treatment fidelity, follow-up, publication, and impact in terms of citations and replication. To date, the Dennis et al. (2004) CYT main findings have been cited over 1,000 times. Dr. Dennis has also participated in the conduct of a half dozen other treatment experiments, development of research-based treatment guidelines, and has chaired both major adolescent treatment associations (JMATE and SASATE). The significance of this work led to his receiving the Joint Meeting on Adolescent Treatment Effectiveness (JMATE) Research to Evidence-Based Practice award for bridging the gap between adolescent treatment research and practice.  

Dr. Dennis and his colleagues developed Recovery Management Checkups (RMC) and demonstrated efficacy in four clinical trials and a quasi-experiment to date. He received a MERIT award (R37DA011323) from NIDA after LI’s first clinical trial and the 2012 Dan Anderson Award for Addiction and Recovery Research for his 2012 paper reporting on the main findings from our second trial. He and his colleagues have also worked with economists to demonstrate that the cost of RMC and increased treatment is offset by reductions in expensive health care utilization (e.g., emergency department visits, hospital stays, psychiatric hospitalization, incarceration), and have replicated this work with the State of Illinois to use RMC to recruit over 1,000 additional clients into methadone treatment. As part of NIDA’s HEAL JCOIN cooperative, LI is currently conducting a fifth experiment with RMC for people with opioid use disorders (OUD) coming from Cook County Jail, a study that is expanding into five other county jails. He has worked with individuals with OUD since 1988 on medications for opioid use disorders (MOUD) treatment initiation, retention, readmission, and recovery support and has experience working within the community, in a variety of MOUD and other types of treatment, as part of continuum of care studies, and as part of studying and managing long-term recovery over periods of 6 months to 19 years.  

To integrate measurement, clinical research, and practice, Dr. Dennis has also led the development of the Global Appraisal of Individual Needs (GAIN) family of measures since 1993. As of June 30, 2023, the GAIN Coordinating Center (www.gaincc.org) has worked with over 21,154 staff from 5,602 agencies (in all 50 states in the U.S., all 10 provinces of Canada, and 14 other countries), teaching them how to utilize the GAIN measures to support clinical decision making related to diagnosis, treatment planning, placement, outcome monitoring, economic evaluation and program/policy planning. The GAIN has also been used in over 900 publications. This includes using formal measurement models to create shorter and more efficient versions of the GAIN to get much of the core information in less time. The significance of this work led to Dr. Dennis receiving the International Council on Alcoholism and Addiction (ICAA) lifetime achievement award for his work with the GAIN. He has been PI, Co-PI, or lead methodologist on a dozen clinical trials, chaired one of NIDA’s data safety monitoring boards, chaired NIAAA’s health services research review group, and served on multiple editorial boards.